![The Walt Disney Company [DIS] Price Analysis: Next Bullish Target is $154.27](https://globalresearchsyndicate.com/wp-content/uploads/2019/12/online-stock-exchange-team-PWS65GA-scaled.jpg)
Amicus Therapeutics, Inc. [FOLD] is following upward trend in the market concluded with the last trading session. The shares of the Healthcare sector company has a current value of $9.46 after FOLD shares went up by 0.96% during the last trading session. One of the reasons why Healthcare stocks may go bullish is increased momentum in the press.
Amicus Therapeutics, Inc. [NASDAQ:FOLD]: Analyst Rating and Earnings
Its stock price has been found in the range of 7.11 to 14.61. This is compared to its latest closing price of $9.37.
Keep your eyes on this company’s next financial results, which are scheduled to be made public on Thu 27 Feb (In 50 Days).
Fundamental Analysis of Amicus Therapeutics, Inc. [FOLD]
Now let’s turn to look at profitability: with a current Operating Margin for Amicus Therapeutics, Inc. [FOLD] sitting at -356.71 and its Gross Margin at +79.59.
This company’s Return on Total Capital is -55.07, and its Return on Invested Capital has reached -49.50%. Its Return on Equity is -100.32, and its Return on Assets is -49.26. These metrics suggest that this Amicus Therapeutics, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.
Turning to investigate this organization’s capital structure, Amicus Therapeutics, Inc. [FOLD] has generated a Total Debt to Total Equity ratio of 93.83. Similarly, its Total Debt to Total Capital is 48.41, while its Total Debt to Total Assets stands at 40.73. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -14.53, and its Long-Term Debt to Total Capital is 93.83.
